United States Biotechnology & Medical Research

Axim Biotechnologies Inc (AXIM)

Track

Track

Ticker: AXIM Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
WILSON-DAVIS & CO., INC. Director Non-Executive Director
Transaction date
Proposed sale
Price
197.53
Quantity 46,818
Value US$3,135,713
Valencia Catalina Large shareholder
Transaction date
Purchase
Price
25.33
Quantity 55,945 -37.9%
Value US$2,194,042
HUEMOELLER JOHN WALTER II Chief Executive Officer Executive Director
Transaction date
Purchase
Price
86.89
Quantity 63,448
Value US$3,611,276
SAMUELS ROSEMARY PRESIDENT, CEO, CFO Executive Director Large shareholder
Transaction date
Sale
Price
400.00
Quantity 1,000,000 -100.0%
Value US$400,000,000
SAMUELS ROSEMARY PRESIDENT, CEO, CFO Executive Director Large shareholder
Transaction date
Sale
Price
8,000.00
Quantity 20,000,000 -100.0%
Value US$160,000,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-10-07 2022-09-15 PrS Proposed sale
WILSON-DAVIS & CO., INC.

Director

Non-Executive Director
46,818
197.53
US$3,135,713 		46,818 197.53 US$3,135,713
2022-08-31 2022-08-24 B Purchase
Valencia Catalina
Large shareholder
55,945 -37.9%
25.33
US$2,194,042 		55,945 -37.9% 25.33 US$2,194,042
2022-09-23 2020-03-19 B Purchase
HUEMOELLER JOHN WALTER II

Chief Executive Officer

Executive Director
63,448
86.89
US$3,611,276 		63,448 86.89 US$3,611,276
2014-04-30 2014-03-21 S Sale SAMUELS ROSEMARY

PRESIDENT, CEO, CFO

Executive Director Large shareholder
1,000,000 -100.0%
400.00
US$400,000,000 		1,000,000 -100.0% 400.00 US$400,000,000
2014-04-30 2014-03-21 S Sale SAMUELS ROSEMARY

PRESIDENT, CEO, CFO

Executive Director Large shareholder
20,000,000 -100.0%
8,000.00
US$160,000,000,000 		20,000,000 -100.0% 8,000.00 US$160,000,000,000
Explore more

More insider trading research around Axim Biotechnologies Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America